Skip to content

A Comparison of Atrial Fibrillation Diagnosis Rates of the Conservative 24-hour Holter Test and Single-Lead Wearable Patches in Patients with Nonatherosclerotic Cerebral Infarction. ((AVANT-GARDE (Comparison of Atrial fibrillation Validation After Non-atheromatous STroke: electrocardiogram compARison for unDetermined Embolism : Prospective cohort study))

A Comparison of Atrial Fibrillation Diagnosis Rates of the Conservative 24-hour Holter Test and Single-Lead Wearable Patches in Patients with Nonatherosclerotic Cerebral Infarction. ((AVANT-GARDE (Comparison of Atrial fibrillation Validation After Non-atheromatous STroke: electrocardiogram compARison for unDetermined Embolism : Prospective cohort study))

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CRIS
Registry ID
KCT0008110
Enrollment
110
Registered
2023-01-13
Start date
2023-02-01
Completion date
Unknown
Last updated
2023-02-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

None listed

Sponsors

The Catholic University of Korea, Eunpyeong St. Mary's Hospital
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: a multi-center prospective cohort study. 1. Acute and subacute cerebral infarction (7 days -6month after stroke onset) 2. Age over 18 years 3. without AF on Admission ECG 4. at least 18-hours or more recording on 24-hour Holter monitoring 5. at least 72-hours or more recording on single lead wearable patch 6. Patients who can use a single-lead wearable patch device and related applications

Exclusion criteria

Exclusion criteria: 1. patients with known AF 2. Patient with valvular heart diseases related to AF (rheumatic mitral stenosis, a mechanical or bioprosthetic heart valve, or mitral valve repair, infective endocarditis) 3. Patients with underlying disease related to AF (binge drinking, recent cardiothoracic and noncardiac surgery (<2weeks), recent ST elevation myocardial infarction (MI) (<3month), pericarditis, myocarditis, hyperthyroidism, electrocution, pneumonia, and pulmonary embolism) 4. Patient with implanted pacemaker 5. LA enlargement =44mm 6. NT-proBNP (N-terminal pro-B-type natriuretic peptide) =1000 pg/mL 7. Patients with advanced systemic disease or coexisting neurological/psychiatric disease 8. Patients with contact dermatitis and other skin disorders 9. Patients who are unable to perform the study with other causes.

Design outcomes

Primary

MeasureTime frame
Detection rate of Atrial Fibrillation

Secondary

MeasureTime frame
Recurrence rates of stroke/TIA

Countries

Korea, Republic of

Contacts

Public ContactEun Hye Lee

The Catholic University of Korea, Eunpyeong St. Mary's Hospital

eunhye813@gmail.com+82-2-2030-3749

Outcome results

None listed

Source: CRIS (via WHO ICTRP) · Data processed: Feb 4, 2026